Exscientia
About:
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
Website: https://www.exscientia.ai
Twitter/X: exscientialtd
Top Investors: BlackRock, Evotec, Bristol-Myers Squibb, Marshall Wace, Novo Holdings
Description:
Exscientia combines human expertise with AI and machine learning to enhance drug discovery. The company focuses on precision engineering of medicine candidates, enabling faster and more efficient development of new treatments. By integrating innovative experimental techniques, Exscientia aims to improve patient outcomes and revolutionize the pharmaceutical industry.
$377M
$10M to $50M
Oxford, Oxfordshire, United Kingdom
2012-01-01
contact(AT)exscientia.co.uk
Andrew Hopkins
251-500
2023-12-05
Public
© 2025 bioDAO.ai